Menu

FDA to Cut Back Hiring of Non-US Citizens

The move appears to be out of step with other HHS agencies.

Aug 14, 2017
Shawna Williams

FDAHiring managers at the US Food and Drug Administration (FDA) will soon be unable to extend offers to non-citizens who have lived in the United States for fewer than three of the past five years, reports STAT. The policy, attributed to changes in the background check procedures needed to procure a government employee ID card, does not appear to be in line with policies at other federal science agencies, STAT finds.

A government policy on the ID cards, implemented in 2008, stipulates that applicants must have lived in the country for at least three of the preceding five years in order to complete the background check—but it also suggests that those who do not meet the requirement can be hired and use a different type of card until eligible.

An FDA document obtained by STAT states that the agency’s hiring change is due to a January 2017 update to that policy. Yet, “an HHS spokesman said the internal document did not include new policies on a residency requirement,” the outlet reports.

See “Scientists Concerned About Future of International Collaboration”

The order, expected to take effect October 1, will not apply to current employees. Nevertheless, two FDA staffers tell STAT they were “dismayed” and “stunned” by the policy change, and that it will affect “a huge chunk of the scientific workforce.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.